Barrier Therapeutics

Barrier Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of a portfolio of innovative drug products to address significant unmet medical needs in the field of dermatology. They currently have several intellectual property-based candidate products for which they have obtained clinical development licenses from third parties, with four candidates advancing into or entering Phase III clinical trials.